Recent research indicates a significant increase in calls to poison control centers involving semaglutide, the active ingredient in popular drugs Ozempic and Wegovy. The spike in incidents followed the federal approval of these medications for weight management, highlighting a growing public health concern regarding administration errors.
Accidental Overdosing on the Rise
According to researchers, the majority of these cases are attributed to accidental dosing mistakes rather than intentional misuse. Patients often struggle with the transition to weekly injectable formats or fail to follow the specific titration schedules required for these medications. Common errors include taking the medication too frequently or starting at a dose that is too high for the body to tolerate initially.
Prevention Through Education
The study suggests that many of these medical emergencies are avoidable. Experts emphasize that clearer education regarding the gradual increase of doses—a process known as titration—and strict adherence to the once-weekly schedule could drastically reduce the number of adverse events. As semaglutide continues to gain popularity, medical professionals are urged to provide more comprehensive training for patients self-administering the drug at home.
